Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Announces Q2 Results (Standalone & Consolidated) & Limited Review Report (Standalone & Consolidated) for the Quarter ended September 30, 2016

 Cadila Healthcare Ltd has announced the following results for the quarter ended September 30, 2016The Unaudited Standalone results for the Quarter ended September 30, 2016 The Company has posted a net profit of Rs. 1090 million for the quarter ended September 30, 2016 as compared to Rs. 6347 million for the quarter ended September 30, 2015. Total Income has decreased from Rs. 20201 million for the quarter ended September 30, 2015...
26-10-2016
Bigul

Post results conference call with investors/ analysts

 Cadila Healthcare Ltd has informed BSE about Post results conference call with investors/ analysts.
19-10-2016
Bigul

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016

 Cadila Healthcare Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
12-10-2016
Bigul

Shareholding for the Period Ended September 30, 2016

 Cadila Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here
12-10-2016
Bigul

Q2 results on Oct 26, 2016

 Cadila Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on October 26, 2016, inter alia, to consider to approve the unaudited financial results for the quarter / half year ended on September 30, 2016 (Q2).Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain...
07-10-2016
Bigul

Zydus signs in-licensing deal with Neovii of Switzerland

 Cadila Healthcare Ltd has informed BSE regarding a Press Release dated October 06, 2016 titled "Zydus signs in-licensing deal with Neovii of Switzerland".
06-10-2016
Bigul

Zydus and Medicines for Malaria Venture Sign Agreement to Develop Potential New Antimalarial Drug

 Cadila Healthcare Ltd has informed BSE regarding a Press Release dated September 30, 2016 titled "Zydus and Medicines for Malaria Venture Sign Agreement to Develop Potential New Antimalarial Drug".
30-09-2016
Bigul

Zydus Cadila ties up with Takeda to develop chikungunya vaccine

 Drug firm Zydus Cadila today announced partnership with Japan's Takeda Pharmaceutical Company Ltd to develop a vaccine for chikungunya. The broad-based agreement includes early stage development to
20-09-2016
Bigul

Zydus and Takeda enter into partnership to address emerging infectious diseases

 Cadila Healthcare Ltd has informed BSE regarding a Press Release dated September 20, 2016 titled "Zydus and Takeda enter into partnership to address emerging infectious diseases"
20-09-2016
Bigul

Cadila Healthcare gains on EIR for Ahmedabad facility

 The stock moved higher by 4% to Rs 391 on the BSE.
02-09-2016
Next Page
Close

Let's Open Free Demat Account